This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Atrion Inkomsten in het verleden

Verleden criteriumcontroles 1/6

De winst van Atrion is gedaald met een gemiddeld jaarlijks percentage van -11.4%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 13.1%. De inkomsten zijn groeide met een gemiddeld percentage van 3.8% per jaar. Het rendement op het eigen vermogen Atrion bedraagt 5.3% en de nettomarge bedraagt 6.9%.

Belangrijke informatie

-11.4%

Groei van de winst

-10.3%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie	8.9%
Inkomstengroei	3.8%
Rendement op eigen vermogen	5.3%
Nettomarge	6.9%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

May 22

Recent updates

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

May 22

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Mar 24

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Mar 23

Opbrengsten en kosten

Hoe Atrion geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NasdaqGS:ATRI Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Jun 24	182	13	37	6
31 Mar 24	177	19	32	7
31 Dec 23	169	19	33	7
30 Sep 23	169	21	33	6
30 Jun 23	171	27	32	6
31 Mar 23	176	30	32	6
31 Dec 22	184	35	31	6
30 Sep 22	181	35	31	6
30 Jun 22	179	34	31	6
31 Mar 22	173	34	29	6
31 Dec 21	165	33	28	6
30 Sep 21	157	32	26	6
30 Jun 21	148	31	25	6
31 Mar 21	143	31	24	5
31 Dec 20	148	32	25	6
30 Sep 20	150	33	25	6
30 Jun 20	155	35	25	5
31 Mar 20	157	36	25	6
31 Dec 19	155	37	25	5
30 Sep 19	156	36	25	5
30 Jun 19	156	36	25	5
31 Mar 19	155	35	25	5
31 Dec 18	152	34	25	6
30 Sep 18	152	35	25	6
30 Jun 18	150	34	24	6
31 Mar 18	147	35	24	6
31 Dec 17	147	37	24	6
30 Sep 17	146	34	23	6
30 Jun 17	146	33	23	6
31 Mar 17	146	31	22	7
31 Dec 16	143	28	22	7
30 Sep 16	143	28	22	6
30 Jun 16	142	28	22	6
31 Mar 16	144	28	22	6
31 Dec 15	146	29	22	6
30 Sep 15	146	29	22	7
30 Jun 15	145	29	22	6
31 Mar 15	143	28	22	6
31 Dec 14	141	28	22	5
30 Sep 14	140	28	22	5
30 Jun 14	137	28	22	5
31 Mar 14	135	27	21	4
31 Dec 13	132	27	21	4
30 Sep 13	129	26	20	4

Kwaliteitswinsten: ATRI heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (6.9%) ATRI } zijn lager dan vorig jaar (15.9%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van ATRI is de afgelopen 5 jaar met 11.4% per jaar gedaald.

Versnelling van de groei: De winstgroei ATRI is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: ATRI had het afgelopen jaar een negatieve winstgroei ( -53.8% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 12.2% ).

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 5.3% ) van ATRI wordt als laag beschouwd.

This company has been acquired

Atrion Inkomsten in het verleden

Verleden criteriumcontroles 1/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Second quarter 2024 earnings released: EPS: US$0.23 (vs US$3.73 in 2Q 2023)

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

First quarter 2024 earnings released: EPS: US$1.59 (vs US$1.98 in 1Q 2023)

Third quarter 2023 earnings released: EPS: US$1.67 (vs US$4.95 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$3.73 (vs US$5.21 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$1.98 (vs US$4.72 in 1Q 2022)

Recent updates

Atrion Corporation(NasdaqGS:ATRI) dropped from NASDAQ Composite Index

Nordson Medical Corporation completed the acquisition of Atrion Corporation (NasdaqGS:ATRI) from a group of shareholders.

Second quarter 2024 earnings released: EPS: US$0.23 (vs US$3.73 in 2Q 2023)

President & CEO exercised options and sold US$141k worth of stock

Upcoming dividend of US$2.20 per share

Nordson Medical Corporation entered into an agreement to acquire Atrion Corporation (NasdaqGS:ATRI) for approximately $820 million.

First quarter dividend of US$2.20 announced

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 28, 2024

First quarter 2024 earnings released: EPS: US$1.59 (vs US$1.98 in 1Q 2023)

Atrion Corporation Provides Production Guidance for the Third Quarter of 2024

Atrion Corporation, Annual General Meeting, May 21, 2024

Investor sentiment improves as stock rises 16%

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Investor sentiment improves as stock rises 23%

Upcoming dividend of US$2.20 per share

Fourth quarter dividend of US$2.20 announced

Investor sentiment improves as stock rises 17%

Here's Why Atrion (NASDAQ:ATRI) Can Manage Its Debt Responsibly

Atrion Corporation's (NASDAQ:ATRI) 26% Share Price Surge Not Quite Adding Up

Investor sentiment improves as stock rises 16%

Independent Director recently bought US$96k worth of stock

Upcoming dividend of US$2.20 per share at 3.0% yield

President & CEO recently bought US$90k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023

New minor risk - Profit margin trend

Third quarter 2023 earnings released: EPS: US$1.67 (vs US$4.95 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Atrion Corporation Announces Election of Jeannette Bankes as Director

Atrion (NASDAQ:ATRI) Seems To Use Debt Quite Sensibly

Upcoming dividend of US$2.20 per share at 1.9% yield

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$3.73 (vs US$5.21 in 2Q 2022)

Atrion (NASDAQ:ATRI) Will Want To Turn Around Its Return Trends

Executive Chairman exercised options and sold US$176k worth of stock

Upcoming dividend of US$2.15 per share at 1.6% yield

Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023

First quarter 2023 earnings released: EPS: US$1.98 (vs US$4.72 in 1Q 2022)

Be Wary Of Atrion (NASDAQ:ATRI) And Its Returns On Capital

Upcoming dividend of US$2.15 per share at 1.4% yield

Full year 2022 earnings released: EPS: US$19.59 (vs US$18.22 in FY 2021)

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of US$2.15 per share

Insufficient new directors

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2022

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Third quarter 2022 earnings released: EPS: US$4.95 (vs US$4.59 in 3Q 2021)

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Insufficient new directors

Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital

Atrion Corporation Announces Resignation of Maria Sainz from the Board of Directors, Effective from October 21, 2022

Atrion: Attractively Priced For Exposure To Defensive Healthcare

Upcoming dividend of US$2.15 per share

CFO, VP exercised options and sold US$51k worth of stock

Atrion's (NASDAQ:ATRI) Upcoming Dividend Will Be Larger Than Last Year's

Atrion Corporation Announces CFO Changes

Atrion Corporation Increases Quarterly Cash Dividend, Payable on September 30, 2022

Atrion raises dividend 10.3% to $2.15/share

Second quarter 2022 earnings released: EPS: US$5.21 (vs US$4.89 in 2Q 2021)

Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital

Executive Chairman exercised options and sold US$582k worth of stock

Atrion Corporation Announces Jeffery Strickland Intends to Retire as Secretary and Treasurer Effective March 3, 2023

Upcoming dividend of US$1.95 per share

CFO, VP exercised options and sold US$79k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

First quarter 2022 earnings released: EPS: US$4.72 (vs US$4.23 in 1Q 2021)